Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Clinical Diagnosis of Gastrointestinal Stromal Tumor (GIST): From the Molecular Genetic Point of View.

Wu CE, Tzen CY, Wang SY, Yeh CN.

Cancers (Basel). 2019 May 16;11(5). pii: E679. doi: 10.3390/cancers11050679. Review.

2.

A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17.

Yeh CN, Chen MH, Chen YY, Yang CY, Yen CC, Tzen CY, Chen LT, Chen JS.

Oncotarget. 2017 Jul 4;8(27):44121-44130. doi: 10.18632/oncotarget.17310.

3.

Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor.

Koo DH, Ryu MH, Kim KM, Yang HK, Sawaki A, Hirota S, Zheng J, Zhang B, Tzen CY, Yeh CN, Nishida T, Shen L, Chen LT, Kang YK.

Cancer Res Treat. 2016 Oct;48(4):1155-1166. Epub 2016 Jun 24.

4.

Hemolytic uremic syndrome caused by enteroviral infection.

Lee MD, Tzen CY, Lin CC, Huang FY, Liu HC, Tsai JD.

Pediatr Neonatol. 2013 Jun;54(3):207-10. doi: 10.1016/j.pedneo.2012.10.012. Epub 2012 Dec 14.

5.

Effective salvage therapy of imatinib-resistant gastrointestinal stromal tumor with combination of imatinib and pegylated liposomal doxorubicin.

Hsieh YY, Yen CC, Yeh CN, Tzen CY, Liu JH, Lee HJ, Teng HW, Tzeng CH, Chiou TJ, Chao TC.

J Chin Med Assoc. 2011 Jun;74(6):272-4. doi: 10.1016/j.jcma.2011.04.007. Epub 2011 May 13.

6.

Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma.

Devitt B, Liu W, Salemi R, Wolfe R, Kelly J, Tzen CY, Dobrovic A, McArthur G.

Pigment Cell Melanoma Res. 2011 Aug;24(4):666-72. doi: 10.1111/j.1755-148X.2011.00873.x. Epub 2011 Jun 22.

PMID:
21615881
7.

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.

Wu IW, Hsu KH, Lee CC, Sun CY, Hsu HJ, Tsai CJ, Tzen CY, Wang YC, Lin CY, Wu MS.

Nephrol Dial Transplant. 2011 Mar;26(3):938-47. doi: 10.1093/ndt/gfq580. Epub 2010 Sep 29.

8.
9.

Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.

Klimstra DS, Modlin IR, Adsay NV, Chetty R, Deshpande V, Gönen M, Jensen RT, Kidd M, Kulke MH, Lloyd RV, Moran C, Moss SF, Oberg K, O'Toole D, Rindi G, Robert ME, Suster S, Tang LH, Tzen CY, Washington MK, Wiedenmann B, Yao J.

Am J Surg Pathol. 2010 Mar;34(3):300-13. doi: 10.1097/PAS.0b013e3181ce1447.

PMID:
20118772
10.

Concomitant exencephaly and limb defects associated with pentalogy of Cantrell.

Chen CP, Tzen CY, Chen CY, Tsai FJ, Wang W.

Taiwan J Obstet Gynecol. 2008 Dec;47(4):476-7. doi: 10.1016/S1028-4559(09)60025-5. No abstract available.

11.

A 12 Mb deletion of 6p24.1-->pter in an 18-gestational-week fetus with orofacial clefting, the Dandy-Walker malformation and bilateral multicystic kidneys.

Chen CP, Tzen CY, Chern SR, Tsai FJ, Hsu CY, Lee CC, Lee MS, Pan CW, Wang W.

Eur J Med Genet. 2009 Jan-Feb;52(1):59-61. doi: 10.1016/j.ejmg.2008.11.003. Epub 2008 Nov 19.

PMID:
19049908
12.

PIK3CA mutation occurs in nasopharyngeal carcinoma but does not significantly influence the disease-specific survival.

Chou CC, Chou MJ, Tzen CY.

Med Oncol. 2009;26(3):322-6. doi: 10.1007/s12032-008-9124-5. Epub 2008 Nov 15.

PMID:
19012001
13.

Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors.

Lim KH, Huang MJ, Chen LT, Wang TE, Liu CL, Chang CS, Liu MC, Hsieh RK, Tzen CY.

Med Oncol. 2008;25(2):207-13. doi: 10.1007/s12032-007-9014-2. Epub 2007 Oct 6.

PMID:
18488160
14.

Prenatal visualization of cebocephaly with a prominent nose in a second-trimester fetus with alobar holoprosencephaly and trisomy 13.

Chen CP, Shih JC, Tzen CY, Chern SR, Lin CJ, Wang W.

Taiwan J Obstet Gynecol. 2008 Mar;47(1):95-7. doi: 10.1016/S1028-4559(08)60064-9. No abstract available.

15.

PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients.

Lai YL, Mau BL, Cheng WH, Chen HM, Chiu HH, Tzen CY.

Ann Surg Oncol. 2008 Apr;15(4):1064-9. doi: 10.1245/s10434-007-9751-7. Epub 2008 Jan 9.

PMID:
18183466
16.

Lack of prognostic value of EGFR mutations in primary resected non-small cell lung cancer.

Lim KH, Huang MJ, Liu HC, Kuo HT, Tzen CY, Hsieh RK.

Med Oncol. 2007;24(4):388-93.

PMID:
17917087
17.

Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.

Wang HM, Huang YW, Huang JS, Wang CH, Kok VC, Hung CM, Chen HM, Tzen CY.

Ann Surg Oncol. 2007 Oct;14(10):3011-8. Epub 2007 Jul 20.

PMID:
17638058
18.

Cloning of genes expressed in cell quiescence: a new function of the ras-recision/lysyl oxidase gene.

Tzen CY, Huang YW, Wang MN.

Chin J Physiol. 2007 Apr 30;50(2):57-62.

PMID:
17608142
19.

Prenatal diagnosis of Fryns syndrome associated with a microdeletion at 8p23.1.

Chen CP, Wang TH, Chen YJ, Chang TY, Liu YP, Tzen CY, Chern SR, Wang W.

Prenat Diagn. 2007 Oct;27(10):967-9. No abstract available.

PMID:
17602449
20.

ND4 mutation in transitional cell carcinoma: Does mitochondrial mutation occur before tumorigenesis?

Tzen CY, Mau BL, Wu TY.

Mitochondrion. 2007 Jul;7(4):273-8. Epub 2007 Apr 24.

PMID:
17509949

Supplemental Content

Loading ...
Support Center